Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2003Diabetes CareOpen Access

The Treat-to-Target Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

MRMatthew C. RiddleOregon Health & Science University
Julio Rosenstock
Julio RosenstockGeneral / Preventive / LipidsJGJohn GerichUniversity of Rochester Medical Center

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Riddle et al. (2003) studied this question.

synapsesocial.com/papers/6a7ca02f041f7ddee0ba5f92https://doi.org/10.2337/diacare.26.11.3080
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparison of Bedtime Insulin Regimens in Patients with Type 2 Diabetes Mellitus1999 · 436 citations
  2. 2Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.2000 · 477 citations
  3. 3Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes Mellitus<SUBTITLE>Progressive Requirement for Multiple Therapies (UKPDS 49)</SUBTITLE>1999 · 2,391 citations